The direct and indirect effects of infection in liver transplantation: pathogenesis, impact, and clinical management.
Rubin
Robert H
RH
Massachusetts General Hospital, USA.
D019072:Antibiotic Prophylaxis / Q000379:methods; D003428:Cross Infection / Q000453:epidemiology; D003587:Cytomegalovirus / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000473:pathology / Q000517:prevention & control; D020031:Epstein-Barr Virus Infections / Q000473:pathology / Q000517:prevention & control; D006518:Hepatitis Viruses / Q000145:classification / Q000472:pathogenicity; D006525:Hepatitis, Viral, Human / Q000145:classification / Q000473:pathology; D004854:Herpesvirus 4, Human / Q000472:pathogenicity; D015654:Herpesvirus 6, Human / Q000472:pathogenicity; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007239:Infections / Q000150:complications / Q000209:etiology* / Q000628:therapy*; D016031:Liver Transplantation / Q000009:adverse effects*; D012307:Risk Factors; D019349:Roseolovirus Infections / Q000473:pathology / Q000517:prevention & control; D013997:Time Factors